$226,185 – $292,710
Listed on Gilead Sciences’s own careers site. You apply with them directly — we never stand between you and the employer.
What this role is
This director-level role leads health economics and outcomes research strategy for Gilead's liver, inflammation, and emerging virus portfolio, partnering across clinical, commercial, and market access functions to build evidence for product value and reimbursement. It suits experienced pharmaceutical health economists with deep expertise in HEOR study design, global value demonstrations, and healthcare system reimbursement who can influence cross-functional strategy.
Our summary, not Gilead Sciences’s wording. The full posting is on their site.
What they ask for
Required
- At least 8 years pharmaceutical industry or managed care experience
- Direct HEOR experience
- Understanding of HEOR assessments
- Technical expertise in HEOR study and model design and execution
- Experience developing global value dossiers
- Understanding of US and global healthcare systems
- Knowledge of reimbursement processes and decision-making
- Strong oral and written communication
- Strong interpersonal skills
Nice to have
- Experience in viral hepatitis
- Experience in primary biliary cholangitis (PBC) US managed care
- Advanced degree in HEOR